Holen Sie sich die Stockscreener-App
2.54
5.19%
-0.16
Handel nachbörslich:
2.54
Schlusskurs vom Vortag:
$2.70
Offen:
$2.55
24-Stunden-Volumen:
183.82K
Relative Volume:
1.18
Marktkapitalisierung:
$115.98M
Einnahmen:
$134.00K
Nettoeinkommen (Verlust:
$-9.93M
KGV:
-7.4706
EPS:
-0.34
Netto-Cashflow:
$-6.72M
1W Leistung:
+35.45%
1M Leistung:
+42.22%
6M Leistung:
+47.13%
1J Leistung:
+43.82%
1-Tages-Spanne:
$2.5161
$2.81
1-Wochen-Bereich:
$1.88
$2.95
52-Wochen-Spanne:
$1.5006
$2.95
Entera Bio Ltd Stock (ENTX) Company Profile
Firmenname
Entera Bio Ltd
Sektor
Branche
Telefon
972-2-532-7151
Adresse
KIRYAT HADASSAH, MINRAV BUILDING, JERUSALEM
Vergleichen Sie ENTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ENTX
Entera Bio Ltd
|
2.54 | 123.29M | 134.00K | -9.93M | -6.72M | -0.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Entera Bio Ltd Stock (ENTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-03-22 | Eingeleitet | Aegis Capital | Buy |
Entera Bio Ltd Aktie (ENTX) Neueste Nachrichten
Technical analysis overview for Entera Bio Ltd. stock2025 Support & Resistance & Safe Entry Zone Tips - newser.com
How Entera Bio Ltd. stock reacts to bond yieldsJuly 2025 Market Mood & Precise Swing Trade Entry Alerts - newser.com
What recovery options are there for Entera Bio Ltd.Quarterly Portfolio Review & High Accuracy Swing Trade Signals - newser.com
What risks investors should watch in Entera Bio Ltd. stockEarnings Risk Summary & Low Drawdown Trading Strategies - newser.com
What Fibonacci levels say about Entera Bio Ltd. reboundEarnings Risk Summary & Precise Entry and Exit Recommendations - newser.com
Tick level data insight on Entera Bio Ltd. volatilityEarnings Growth Summary & Weekly Market Pulse Updates - newser.com
Predicting Entera Bio Ltd. trend using moving averagesMarket Sentiment Report & Verified Swing Trading Watchlist - newser.com
How rising interest rates impact Entera Bio Ltd. stock2025 Historical Comparison & Verified Short-Term Plans - newser.com
How Entera Bio Ltd. stock reacts to inflationary pressuresJuly 2025 Rallies & Daily Price Action Insights - newser.com
How to build a dashboard for Entera Bio Ltd. stockGap Down & Long-Term Capital Growth Strategies - newser.com
Is it too late to sell Entera Bio Ltd.July 2025 WrapUp & AI Powered Buy/Sell Recommendations - newser.com
Can swing trading help recover from Entera Bio Ltd. lossesDividend Hike & AI Forecast for Swing Trade Picks - newser.com
Individual investors among Entera Bio Ltd.'s (NASDAQ:ENTX) largest shareholders, saw gain in holdings value after stock jumped 39% last week - simplywall.st
Individual investors are Entera Bio Ltd.'s (NASDAQ:ENTX) biggest owners and were rewarded after market cap rose by US$34m last week - Yahoo Finance
Can Entera Bio Ltd. (5DT) stock reach $200 price targetRisk Management & Consistent Profit Alerts - newser.com
Entera Bio Ltd. stock trend forecastPortfolio Return Summary & AI Driven Stock Reports - newser.com
Key metrics from Entera Bio Ltd.’s quarterly dataMarket Rally & Long-Term Growth Stock Strategies - newser.com
Multi asset correlation models including Entera Bio Ltd.2025 Technical Patterns & Consistent Profit Trade Alerts - newser.com
Will Entera Bio Ltd. stock go up soonJuly 2025 Review & Reliable Momentum Entry Alerts - newser.com
How analysts revise price targets for Entera Bio Ltd. (5DT) stockQuarterly Trade Review & Breakout Confirmation Trade Signals - newser.com
Weiss Ratings Reaffirms “Sell (D-)” Rating for Entera Bio (NASDAQ:ENTX) - Defense World
Could Oral Osteoporosis Treatment Become the Next GLP-1-Style Blockbuster? - openPR.com
What analysts say about Entera Bio Ltd stockPortfolio Allocation Tips & Market Volatility Strategies - earlytimes.in
Critical Analysis: Precigen (NASDAQ:PGEN) and Entera Bio (NASDAQ:ENTX) - Defense World
Is Entera Bio Ltd. stock positioned for long term growth2025 Institutional Moves & Real-Time Stock Movement Alerts - newser.com
How Entera Bio Ltd. (5DT) stock stacks up against competitorsInsider Buying & Breakout Confirmation Trade Signals - newser.com
How to build a custom watchlist for Entera Bio Ltd.2025 AllTime Highs & Detailed Earnings Play Alerts - newser.com
Long term hold vs stop loss in Entera Bio Ltd.2025 Earnings Surprises & Daily Stock Trend Reports - newser.com
Entera Bio Announces Second Quarter 2025 Financial Results and Business Updates - ADVFN
What drives Entera Bio Ltd 5DT stock priceInstitutional Holding Changes & Free Skyrocketing Profit Margins - earlytimes.in
Hypoparathyroidism Market To Experience Notable Growth In Forecast Span By 2034, Delveinsight Predicts Bridgebio/Calcil Ytix Therapeutics, Ascendis Pharma, Enterabio, Shire - Menafn.com
Entera Bio (NASDAQ:ENTX) Trading Up 7.1% – What’s Next? - Defense World
Entera Bio Ltd 5DT Stock Analysis and ForecastFederal Reserve Announcements & Set Up Real-Time Alerts – It’s Free - earlytimes.in
Finanzdaten der Entera Bio Ltd-Aktie (ENTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):